Drawing for EVOLVE BIOLOGICS

USPTO serial 87717949

EVOLVE BIOLOGICS

Reviewed by CopyMark Law Group

Reg. 6297748Status 700Renewal
Filing date
Status date
Registration date
Mar 23, 2021
Examiner
MORENO, PAUL A
Law office
TMEG LAW OFFICE 103

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with EVOLVE BIOLOGICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,795*

Plus Government fees of $1,625

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Christopher J. Schulte

Christopher J. Schulte MERCHANT & GOULD P.C.P.O. Box 2910Minneapolis, MN 55402-0910UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for human clinical use, namely, plasma protein fractions, serum albumin, immunoglobulins, coagulation factors, antihemophilic factors, clotting factors, enzymes, coenzymes, coactivators, inhibitors, and structural proteins; resins, for medical use, namely, polysaccharide beads cross-linked to ligands for capturing proteins from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate using chromatographic methodsACTIVE—
037Construction of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate; consulting services concerning construction of biotech; Consulting services concerning building construction of biotech facilitiesACTIVE—
040Contract manufacturing services for others for biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, and clinical use; consulting services concerning manufacturing of biologicsACTIVE—
041Educational services, namely, designing, arranging, and conducting training programs for research and development, manufacturing of biologics, design, construction, and use of chromatography equipmentACTIVE—
042Development of pharmaceutical preparations and medicines, namely, development services for others for the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development; consulting services for others concerning the capture of biologics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitate for research and development, design and construction of chromatography equipment, and design of biotech, biopharmaceutical and plasma manufacturing facilities, namely, scientific research and evaluation, and engineering; Design of biotech, biopharmaceutical and plasma manufacturing facilities relevant to the manufacturing of biolotics from human blood, human blood plasma, fractionated human blood plasma, cryopaste, and cryoprecipitateACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 23, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 7, 2021CORVREVIEW OF CORRESPONDENCE COMPLETE - INFORMATION MADE OF RECORD—
Jul 7, 2021COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Jul 1, 2021PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 19, 2021ES7RTEAS SECTION 7 REQUEST RECEIVED—
Mar 23, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jan 5, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Jan 5, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Dec 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Dec 1, 2020PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Nov 26, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 25, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 25, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Nov 25, 2020TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 6, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 6, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 25, 2020LOPTLETTER OF PROTEST EVIDENCE FORWARDED—
Feb 12, 2020GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2020GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 12, 2020CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jan 28, 2020ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Jan 14, 2020PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Jan 1, 2020ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Dec 30, 2019FIXDELECTRONIC RECORD REVIEW COMPLETE—
Dec 27, 2019ERRRON HOLD - ELECTRONIC RECORD REVIEW REQUIRED—
Dec 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Dec 18, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Dec 18, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Dec 13, 2019ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Nov 27, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Oct 30, 2019ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY—
Jun 19, 2019GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED—
Jun 19, 2019GNSIINQUIRY TO SUSPENSION E-MAILED—
Jun 19, 2019CNSISUSPENSION INQUIRY WRITTEN—
Nov 30, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Nov 30, 2018GNSLLETTER OF SUSPENSION E-MAILED—
Nov 30, 2018CNSLSUSPENSION LETTER WRITTEN—
Nov 7, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Nov 7, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 30, 2018ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
May 3, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
May 3, 2018GNSLLETTER OF SUSPENSION E-MAILED—
May 3, 2018CNSLSUSPENSION LETTER WRITTEN—
May 3, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 3, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 1, 2018ALIEASSIGNED TO LIE—
Apr 24, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 16, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 16, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2018DOCKASSIGNED TO EXAMINER—
Dec 22, 2017NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 15, 2017NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance